Testing Henagliflozin for Weight Loss in Obesity Without Diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests if the drug Henagliflozin can help people with obesity (but without diabetes) lose weight. It is a 4th phase trial, meaning the drug is already approved for other uses and is now being studied for weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You do not have diabetes (confirmed by blood tests).
- Your body mass index (BMI) is 28 or higher.
- Your weight has been stable (no more than a 5 kg change) in the last 3 months.
- You have not used weight-loss drugs or similar medications in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medicine called henagliflozin can help reduce fat in the liver for people with type 2 diabetes and non-alcoholic fatty liver disease. It may help improve liver health and blood sugar control at the same time.
This study tests how safe and effective the diabetes medication henagliflozin is for Chinese patients with type 2 diabetes. It is an observational study, meaning you will continue your regular care while researchers watch your progress.
This trial tests whether a combination of two diabetes medicines, henagliflozin and metformin, can improve body composition (fat and muscle) in older adults new to diabetes treatment. It may help you better manage blood sugar and body weight.
This trial studies whether erugliflozin can reduce liver fat and liver scarring (fibrosis) while also improving blood sugar in people with type 2 diabetes and fatty liver disease (NASH/NAFLD). It’s designed for people who haven’t used certain diabetes medicines like SGLT2 inhibitors or insulin before.
This study tests two different medicines (empagliflozin or semaglutide) added to your usual insulin to see if they help with blood sugar control and weight loss in people with type 1 diabetes who are overweight or have obesity. It may be a good fit if your diabetes is not well controlled with insulin injections alone.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
Hear when a new Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.